BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR. Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol 2012;25:189-99. [PMID: 22988337 DOI: 10.1293/tox.25.189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Tulessin M, Sarker RSJ, Griger J, Leibing T, Geraud C, Weichert W, Steiger K, Mogler C. Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis. Cells 2022;11:2129. [DOI: 10.3390/cells11142129] [Reference Citation Analysis]
2 Yamada T, Lake BG, Cohen SM. Evaluation of the human hazard of the liver and lung tumors in mice treated with permethrin based on mode of action. Crit Rev Toxicol 2022;:1-31. [PMID: 35275035 DOI: 10.1080/10408444.2022.2035316] [Reference Citation Analysis]
3 Cooper TK, Meyerholz DK, Beck AP, Delaney MA, Piersigilli A, Southard TL, Brayton CF. Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits. ILAR J 2022:ilab022. [PMID: 34979559 DOI: 10.1093/ilar/ilab022] [Reference Citation Analysis]
4 Goto RL, Tablas MB, Prata GB, Espírito Santo SG, Fernandes AAH, Cogliati B, Barbisan LF, Romualdo GR. Vitamin D3 supplementation alleviates chemically-induced cirrhosis-associated hepatocarcinogenesis. J Steroid Biochem Mol Biol 2022;215:106022. [PMID: 34774723 DOI: 10.1016/j.jsbmb.2021.106022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Blidisel A, Marcovici I, Coricovac D, Hut F, Dehelean CA, Cretu OM. Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective. Cancers (Basel) 2021;13:3651. [PMID: 34359553 DOI: 10.3390/cancers13153651] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Yamada T, Cohen SM, Lake BG. Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit Rev Toxicol 2021;:1-22. [PMID: 34264181 DOI: 10.1080/10408444.2021.1939654] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Oh SH, Ahn JS, Oh EJ, Kim YJ, Yook JM, Lim JH, Jung HY, Choi JY, Kim CD, Park SH, Kim YL, Cho JH. Single-Dose Toxicity Study on ML171, a Selective NOX1 Inhibitor, in Mice. Biomed Res Int 2021;2021:5515478. [PMID: 34195263 DOI: 10.1155/2021/5515478] [Reference Citation Analysis]
8 Ducos C, Pinson-Gadais L, Chereau S, Richard-Forget F, Vásquez-Ocmín P, Cerapio JP, Casavilca-Zambrano S, Ruiz E, Pineau P, Bertani S, Ponts N. Natural Occurrence of Mycotoxin-Producing Fusaria in Market-Bought Peruvian Cereals: A Food Safety Threat for Andean Populations. Toxins (Basel) 2021;13:172. [PMID: 33672426 DOI: 10.3390/toxins13020172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alansari WS, Eskandrani AA. The Anticarcinogenic Effect of the Apple Polyphenol Phloretin in an Experimental Rat Model of Hepatocellular Carcinoma. Arab J Sci Eng 2020;45:4589-97. [DOI: 10.1007/s13369-020-04478-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
10 Lake BG, Price RJ, Scott MP, Chatham LR, Vardy A, Osimitz TG. Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance. Toxicology 2020;439:152465. [PMID: 32320717 DOI: 10.1016/j.tox.2020.152465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wiemann C, Goettel M, Vardy A, Elcombe BM, Elcombe CR, Chatham LR, Wang H, Li L, Buesen R, Honarvar N, Treumann S, Marxfeld H, Groeters S, Lake BG. Metazachlor: Mode of action analysis for rat liver tumour formation and human relevance. Toxicology 2019;426:152282. [DOI: 10.1016/j.tox.2019.152282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
12 Laube B, Michaelsen S, Meischner V, Hartwig A, Epe B, Schwarz M. Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commission. Regul Toxicol Pharmacol 2019;108:104444. [PMID: 31433998 DOI: 10.1016/j.yrtph.2019.104444] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Iwako H, Tashiro H, Okimoto S, Yamaguchi M, Abe T, Kuroda S, Kobayashi T, Ohdan H. Antithrombin Insufficiency Promotes Susceptibility to Liver Tumorigenesis. J Surg Res 2019;236:198-208. [PMID: 30694755 DOI: 10.1016/j.jss.2018.11.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhang HE, Henderson JM, Gorrell MD. Animal models for hepatocellular carcinoma. Biochim Biophys Acta Mol Basis Dis 2019;1865:993-1002. [PMID: 31007176 DOI: 10.1016/j.bbadis.2018.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
15 Cano L, Cerapio JP, Ruiz E, Marchio A, Turlin B, Casavilca S, Taxa L, Marti G, Deharo E, Pineau P, Bertani S. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America. Sci Rep 2018;8:9945. [PMID: 30061721 DOI: 10.1038/s41598-018-28286-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Peffer RC, Lebaron MJ, Battalora M, Bomann WH, Werner C, Aggarwal M, Rowe RR, Tinwell H. Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. Regulatory Toxicology and Pharmacology 2018;96:106-20. [DOI: 10.1016/j.yrtph.2018.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
17 Lake BG. Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. Toxicol Res (Camb) 2018;7:697-717. [PMID: 30090615 DOI: 10.1039/c8tx00008e] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
18 Moore MM, Schoeny RS, Becker RA, White K, Pottenger LH. Development of an adverse outcome pathway for chemically induced hepatocellular carcinoma: case study of AFB1, a human carcinogen with a mutagenic mode of action. Crit Rev Toxicol 2018;48:312-37. [PMID: 29431554 DOI: 10.1080/10408444.2017.1423462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
19 Moreira AJ, Rodrigues GR, Bona S, Fratta LXS, Weber GR, Picada JN, dos Santos JL, Cerski CT, Marroni CA, Marroni NP. Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats. Protoplasma 2017;254:911-20. [DOI: 10.1007/s00709-016-1000-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
20 Mitchell J, Tinkey PT, Avritscher R, Van Pelt C, Eskandari G, Konnath George S, Xiao L, Cressman E, Morris JS, Rashid A, Kaseb AO, Amin HM, Uthamanthil R. Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs. Oncology 2016;91:90-100. [PMID: 27305144 DOI: 10.1159/000446074] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Moreira AJ, Rodrigues G, Bona S, Cerski CT, Marroni CA, Mauriz JL, González-Gallego J, Marroni NP. Oxidative stress and cell damage in a model of precancerous lesions and advanced hepatocellular carcinoma in rats. Toxicol Rep 2015;2:333-40. [PMID: 28962366 DOI: 10.1016/j.toxrep.2014.11.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
22 Perra A, Kowalik MA, Ghiso E, Ledda-Columbano GM, Di Tommaso L, Angioni MM, Raschioni C, Testore E, Roncalli M, Giordano S, Columbano A. YAP activation is an early event and a potential therapeutic target in liver cancer development. J Hepatol. 2014;61:1088-1096. [PMID: 25010260 DOI: 10.1016/j.jhep.2014.06.033] [Cited by in Crossref: 134] [Cited by in F6Publishing: 134] [Article Influence: 16.8] [Reference Citation Analysis]
23 Hsu SH, Wang B, Kutay H, Bid H, Shreve J, Zhang X, Costinean S, Bratasz A, Houghton P, Ghoshal K. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol 2013;183:1719-30. [PMID: 24113455 DOI: 10.1016/j.ajpath.2013.08.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
24 Bannasch P. Comparative Aspects of Rat and Human Hepatocellular Preneoplasia and Neoplasia. J Toxicol Pathol 2013;26:259-62. [DOI: 10.1293/tox..] [Reference Citation Analysis]